Osama Saher

873 total citations
19 papers, 280 citations indexed

About

Osama Saher is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmaceutical Science. According to data from OpenAlex, Osama Saher has authored 19 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmaceutical Science. Recurrent topics in Osama Saher's work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Advanced Drug Delivery Systems (4 papers). Osama Saher is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Advanced Drug Delivery Systems (4 papers). Osama Saher collaborates with scholars based in Egypt, Sweden and Iraq. Osama Saher's co-authors include Dalia Ghorab, Dhanu Gupta, Samir EL Andaloussi, Smith Rjh, Rula Zain, Sadek Ahmed, Jeremy Bost, Daniel W. Hagey, André Görgens and Karin E. Lundin and has published in prestigious journals such as Journal of Controlled Release, Science Advances and Molecules.

In The Last Decade

Osama Saher

18 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osama Saher Egypt 12 153 51 47 29 25 19 280
Jianhu Li China 11 134 0.9× 9 0.2× 69 1.5× 37 1.3× 30 1.2× 23 322
Fatemeh Mehryab Iran 7 204 1.3× 37 0.7× 105 2.2× 7 0.2× 7 0.3× 16 292
Jin Hee Kang South Korea 11 98 0.6× 16 0.3× 45 1.0× 22 0.8× 7 0.3× 22 486
Narges Mardi Iran 10 322 2.1× 22 0.4× 144 3.1× 17 0.6× 29 1.2× 16 408
Karel Švojgr Czechia 8 65 0.4× 18 0.4× 13 0.3× 30 1.0× 6 0.2× 16 154
Mengxue Xu China 5 239 1.6× 47 0.9× 101 2.1× 10 0.3× 9 0.4× 12 404
Jeongah Lim South Korea 9 86 0.6× 16 0.3× 10 0.2× 9 0.3× 19 0.8× 13 373
Jinlong Qin China 10 132 0.9× 15 0.3× 73 1.6× 12 0.4× 14 0.6× 22 285
Jeremy Bost Sweden 9 325 2.1× 9 0.2× 107 2.3× 6 0.2× 15 0.6× 12 389
Tengfei He United States 11 173 1.1× 26 0.5× 17 0.4× 4 0.1× 10 0.4× 14 446

Countries citing papers authored by Osama Saher

Since Specialization
Citations

This map shows the geographic impact of Osama Saher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osama Saher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osama Saher more than expected).

Fields of papers citing papers by Osama Saher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osama Saher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osama Saher. The network helps show where Osama Saher may publish in the future.

Co-authorship network of co-authors of Osama Saher

This figure shows the co-authorship network connecting the top 25 collaborators of Osama Saher. A scholar is included among the top collaborators of Osama Saher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osama Saher. Osama Saher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ahmed, Sadek, et al.. (2025). Development and characterization of fenticonazole nitrate-loaded cubogel for the management of vaginal candidiasis. International Journal of Pharmaceutics X. 10. 100355–100355. 11 indexed citations
2.
Saher, Osama, Марек Напиерала, Jill S. Napierala, et al.. (2025). Anti-gene oligonucleotides targeting Friedreich’s ataxia expanded GAA⋅TTC repeats increase Frataxin expression. Molecular Therapy — Nucleic Acids. 36(2). 102541–102541.
4.
Ahmed, Sadek, et al.. (2025). Novel hybrid tri-polymer hyalurosomes: unlocking next-generation trans-tympanic therapeutics through multi-Scale evaluations. International Journal of Pharmaceutics X. 10. 100425–100425. 5 indexed citations
5.
Gustafsson, Oskar, Xiuming Liang, Osama Saher, et al.. (2025). Advanced peptide nanoparticles enable robust and efficient delivery of gene editors across cell types. Journal of Controlled Release. 386. 114038–114038. 3 indexed citations
6.
Ahmed, Sadek, et al.. (2024). Augmented glycerosomes as a promising approach against fungal ear infection: Optimization and microbiological, ex vivo and in vivo assessments. International Journal of Pharmaceutics X. 8. 100295–100295. 17 indexed citations
7.
Mamand, Doste R., Mohammad H. Forouzanfar, Osama Saher, et al.. (2024). Tumor cell derived osteopontin and prostaglandin E2 synergistically promote the expansion of myeloid derived suppressor cells during the tumor immune escape phase. International Immunopharmacology. 129. 111584–111584. 2 indexed citations
8.
Hagey, Daniel W., Miina Ojansivu, Rakibe Beklem Bostancıoğlu, et al.. (2023). The cellular response to extracellular vesicles is dependent on their cell source and dose. Science Advances. 9(35). eadh1168–eadh1168. 49 indexed citations
9.
Saher, Osama, Eman M. Zaghloul, Daniel W. Hagey, et al.. (2023). Chemical Modifications and Design Influence the Potency of Huntingtin Anti-Gene Oligonucleotides. Nucleic Acid Therapeutics. 33(2). 117–131. 5 indexed citations
10.
Bost, Jeremy, Osama Saher, Daniel W. Hagey, et al.. (2021). Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles. Advanced Healthcare Materials. 11(5). e2101658–e2101658. 40 indexed citations
11.
12.
Olsson, Thomas, Olof Gissberg, Osama Saher, et al.. (2021). Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System. Nucleic Acid Therapeutics. 31(6). 443–456. 5 indexed citations
13.
Saher, Osama, Jeremy Bost, Marc Heitz, et al.. (2021). Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides. Pharmaceutics. 13(1). 116–116. 14 indexed citations
14.
Estupiñán, H. Yesid, Thibault Bouderlique, Chenfei He, et al.. (2020). Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects. Blood Advances. 4(11). 2439–2450. 18 indexed citations
15.
Saher, Osama, Taavi Lehto, Olof Gissberg, et al.. (2019). Sugar and Polymer Excipients Enhance Uptake and Splice-Switching Activity of Peptide-Dendrimer/Lipid/Oligonucleotide Formulations. Pharmaceutics. 11(12). 666–666. 12 indexed citations
16.
Saher, Osama, et al.. (2019). Oligonucleotide–Palladacycle Conjugates as Splice-Correcting Agents. Molecules. 24(6). 1180–1180. 11 indexed citations
17.
Saher, Osama, Eman M. Zaghloul, Oscar P. B. Wiklander, et al.. (2018). Novel peptide-dendrimer/lipid/oligonucleotide ternary complexes for efficient cellular uptake and improved splice-switching activity. European Journal of Pharmaceutics and Biopharmaceutics. 132. 29–40. 18 indexed citations
18.
Saher, Osama, et al.. (2015). Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis. Pharmaceutical Development and Technology. 21(5). 600–610. 28 indexed citations
19.
Saher, Osama, et al.. (2015). Levofloxacin hemihydrate ocular semi-sponges for topical treatment of bacterial conjunctivitis: Formulation and in-vitro/in-vivo characterization. Journal of Drug Delivery Science and Technology. 31. 22–34. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026